Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient. 
This report contains market size and forecasts of Gene Therapy in Oncology in Global, including the following market information:
Global Gene Therapy in Oncology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gene Therapy in Oncology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ex Vivo Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gene Therapy in Oncology include Bristol-Myers Squibb, Cold Genesys, Advantagene, Amgen, AstraZeneca, Bio-Path Holdings, CRISPR Therapeutics, Editas Medicine and Geron Corp, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Therapy in Oncology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy in Oncology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gene Therapy in Oncology Market Segment Percentages, by Type, 2021 (%)
Ex Vivo
In Vivo
Global Gene Therapy in Oncology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gene Therapy in Oncology Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostics Centers
Research Institutes
Global Gene Therapy in Oncology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gene Therapy in Oncology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapy in Oncology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gene Therapy in Oncology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Cold Genesys
Advantagene
Amgen
AstraZeneca
Bio-Path Holdings
CRISPR Therapeutics
Editas Medicine
Geron Corp
Idera Pharmaceuticals
Intellia Therapeutics
Johnson & Johnson
Marsala Biotech
Merck
Mologen AG
Oncolytics Biotech
Oncosec
Oncotelic
Shenzhen SiBiono GeneTech
Sillajen Biotherapeutics
Tocagen
UniQure
Ziopharm Oncology